Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option
Long-term treatment with systemic rifampicin and clindamycin for epidermal growth factor receptor inhibitor-related acneiform and mucocutaneous rash. a valid therapeutic option / Paolino, Giovanni; Caro, Raffaele Dante Caposiena; Valenti, Mario; Carugno, Andrea; Di Nicola, Matteo Riccardo; Cantisani, Carmen; Mercuri, Santo Raffele; Didona, Dario. - In: INTERNATIONAL JOURNAL OF DERMATOLOGY. - ISSN 0011-9059. - 65:4(2025), pp. 851-856. [10.1111/ijd.70123]
Long-term treatment with systemic rifampicin and clindamycin for epidermal growth factor receptor inhibitor-related acneiform and mucocutaneous rash. a valid therapeutic option
Paolino, Giovanni;Cantisani, Carmen;
2025
Abstract
Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option| File | Dimensione | Formato | |
|---|---|---|---|
|
Paolino_Long‐Term_2025.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
291.94 kB
Formato
Adobe PDF
|
291.94 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
